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A common feature of chaperone-proteases is archi-
tectural two-fold symmetry across the proteolytic
cylinder. Here we investigate the role of symmetry
for the function of ClpAP and ClpXP assemblies. We
generated asymmetric ClpP particles in which the
two rings differ in ClpA and ClpX binding capability
and/or in proteolytic activity. Rapid-kinetic fluores-
cence measurements and steady-state experiments
indicate that single 2:1 ClpAP or ClpXP complexes
are as efficient in substrate degradation as two 1:1
ClpAP or ClpXP assemblies. This implies that the
two chaperone components work independently.
However, an asymmetric ClpP particle composed of
one active and one inactive ring can stimulate
ATPase activity of ClpA regardless of whether ClpA
binds to the active ring or to the opposite side of
ClpP, across the ring of inactivated protease. Thus,
we propose that conformational transitions in ClpP
are concerted and allosteric effects are transferred
simultaneously to both associated chaperones,
leading to synchronized activation.
INTRODUCTION
Selective protein degradation is an essential part of overall cell
metabolism as well as an important regulatory mechanism
(Bukau et al., 2006; Gottesman, 2003; Wickner et al., 1999).
Energy-dependent proteases in all kingdoms of life are assem-
bled as ring-stacking structures where a chaperone ring, gener-
ally a AAA ATPase (ATPase associated with various cellular
activities), flanks one or both ends of a protease cylinder.
Substrate recognition and unfolding is performed by the chap-
erone, which then translocates the substrate into the protease
cylinder. Multiple protease active sites are sequestered inside
the protease cylinder, resulting in rapid degradation of
substrates into small peptides consisting of 5–10 amino acids
(Choi and Licht, 2005).
The ClpAP and ClpXP complexes from Escherichia coli consist
of the chaperone rings ClpA or ClpX and the protease cylinder
ClpP (Katayama-Fujimura et al., 1987). The active form of both
ClpA and ClpX is a hexameric, toroidal structure formed in the
presence of ATP or certain nonhydrolyzable analogs (Kress508 Structure 17, 508–516, April 15, 2009 ª2009 Elsevier Ltd All righet al., 2007; Maurizi, 1991; Maurizi et al., 1998). The ClpA as
well as ClpX chaperones bind one substrate per hexamer (Piszc-
zek et al., 2005), and can unfold the substrate even in the
absence of the interaction with the protease ClpP (Weber-Ban
et al., 1999). The best-described substrate recognition motif
for both ClpA and ClpX is an 11 amino acid sequence referred
to as the ssrA tag, which is added to the C terminus of polypep-
tides by the tmRNA system to rescue stalled ribosomes and to
target the truncated proteins for degradation (Farrell et al.,
2005; Gottesman et al., 1998). N-end rule proteins are another
class of substrates with certain hydrophobic residues on their
N termini that are degraded by ClpAP in the presence of the
adaptor protein ClpS (Erbse et al., 2006; Mogk et al., 2007). In
the absence of ClpS or ssrA-tagged substrates, ClpA is itself
a substrate and is degraded by ClpAP (Gottesman et al., 1990;
Maglica et al., 2008).
Association of ClpA and ClpX with ClpP is mediated by at least
two structural features: first, the IGL/F loops of ClpA/X, respec-
tively, interact with the hydrophobic grooves on the surface of
ClpP. The second feature consists of N-terminal residues
protruding from the apical surface of the ClpP cylinder to interact
with the pore-2 loop of ClpX and a still unidentified loop of ClpA
(Bewley et al., 2006; Gribun et al., 2005; Kim et al., 2001; Martin
et al., 2007).
ClpP is a highly conserved protease present in bacteria and
eukaryotes (Yu and Houry, 2007). The subunits assemble into
a tetradecameric, symmetric, cylinder-like structure of about
300 kDa. The two back-to-back stacked heptameric rings form
an internal chamber of 51 A˚ in diameter which can accommo-
date proteins up to about 50 kDa in size (Wang et al., 1997).
Close to the ring-ring interface are 14 proteolytically active serine
residues responsible for degradation of the protein substrates
into small peptides (Choi and Licht, 2005; Wang et al., 1997).
Upon degradation, peptide products are released from the
ClpP chamber through side pores formed on the interface of
the two rings (Gribun et al., 2005; Sprangers et al., 2005). The
entrance into the protease chamber on top of the ClpP ring
has a diameter of 10 A˚, allowing the entry only of small peptides,
whereas larger peptides and unfolded proteins need to be trans-
located by ClpA or ClpX to be efficiently degraded.
The ClpA and ClpX chaperones can be bound on one or both
ends of the ClpP cylinder, forming either a 1:1 or a 2:1 ClpAP or
ClpXP complex. The mixed complex made of both chaperones
ClpA and ClpX bound on opposite ends of ClpP has been
observed in vitro and likely also exists in E. coli (Grimaud et al.,
1998). To date, there is very little known about the functionalts reserved
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ClpAP and ClpXP Architectural Symmetryconsequences of having symmetrically built complexes. The two
studies investigating the activity of ClpP with either one or two
ClpA or ClpX bound showed contradictory results (Maurizi
et al., 1998; Ortega et al., 2002). A study on ClpAP observed
no increase in casein degradation when a second chaperone
was bound to the complex (Maurizi et al., 1998). In contrast, an
analogous investigation with ClpXP indicated that the presence
of the second chaperone makes the complex twice as active
(Ortega et al., 2002).
Because there is cooperativity in the formation of 2:1 ClpAP
complexes (Kress et al., 2007), symmetric 2:1 ClpAP particles
will be preferentially formed even when mixing ClpA and ClpP
in a 1:1 ratio. This makes it difficult to obtain and analyze the
behavior of a homogeneous population of 1:1 or 2:1 ClpAP
complexes by mixing ClpA and ClpP in different ratios. There-
Figure 1. Preparation of Asymmetric ClpP Complexes
(A) His-tagged ClpP (gray ovals with black line denoting the His tag) and an
excess of ClpP particles without a tag (patterned ovals) first undergo a cycle
of ClpP double-ring dissociation and association. The formed asymmetric
ClpP complexes are then isolated by affinity- and anion-exchange chromatog-
raphy and the remaining His tags are cleaved off with TEV protease.
(B) Schematic representations of generated ClpP asymmetric particles in
complex with ClpA chaperone. Active ClpP rings (gray) or rings composed
of hydrolysis-inactive subunits (dark gray) are associated with ClpP rings
that, due to an N-terminal mutation (triangles), are incapable of interacting
with ClpA or ClpX chaperones.Structure 17fore, to study the effects of two chaperone molecules bound to
ClpP, compared to just one ClpA or ClpX bound, we generated
an asymmetric ClpP particle capable of binding only one ClpA
or ClpX chaperone yielding only 1:1 ClpAP or ClpXP complexes.
Furthermore, the importance of symmetry of the ClpP particle
was investigated by generating ClpP double rings in which only
one ring was proteolysis competent. Our results demonstrate
that two 1:1 ClpAP and ClpXP complexes are necessary to
replace single 2:1 ClpAP or ClpXP assemblies. Furthermore,
the ClpP particle was found to adopt two states corresponding
to a proteolysis-active and an -inactive form, facilitated by
allosteric signals across the ring-ring interface, enabling the
whole ClpP particle to adopt the same conformational state in
both rings.
RESULTS
Formation of ClpP Cylinders Composed of TwoDifferent
Rings by Controlled Dissociation and Reassociation
ClpP consists of two back-to-back stacked heptameric rings,
enabling it to interact either with two ClpA or with two ClpX
chaperone rings. These ClpP double rings can be dissociated
into single rings by a change in ionic strength and temperature
without disrupting the intersubunit contacts within one ring
(Maurizi et al., 1998). The same study showed that the rings
can reassociate to form the stable 14-mer when conditions are
reverted. We carried out an extensive analysis of the conditions
important for dissociation and reassociation of ClpP rings. In
addition to ionic strength, we identified glycerol as a crucial
component influencing double-ring stability. In the presence
of 15% glycerol, even extremely high concentrations of salt
(>2 M KCl) did not cause the rings to dissociate. In the absence
of glycerol, salt concentrations higher than 0.3 M KCl were
sufficient to significantly destabilize the ring-ring interactions.
At low ionic strength, that is, when ClpP double rings are stably
associated, the peptidase activity of ClpP is not affected by the
presence or absence of glycerol (data not shown).
Based on the influence of buffer conditions on the stability of
the ClpP ring-ring interaction, we developed a dissociation-
association methodology to generate ClpP cylinders composed
of two different rings (Figure 1A). By introducing a cleavable His
tag on one part of the ClpP population and after a round of ring
dissociation-association, we selectively isolated asymmetric
ClpP particles (ClpPasy) by His-tag affinity and anion-exchange
chromatography. The peptidase activity of ClpPasy was not
altered after rounds of dissociation and reassociation, and iso-
lated ClpPasy did not dissociate over an observation period of
several weeks if kept in the presence of 15% glycerol (see Exper-
imental Procedures).
This methodology was used to generate several ClpP particles
that are asymmetric across the ring-ring interface by combining
wild-type ClpP (ClpPwt), proteolytically inactive ClpP (ClpPinac)
(Maurizi, 1991), ClpP that is ClpA/X-binding incompetent but still
has full peptidase activity (ClpPV6A) (Bewley et al., 2006), as well
as the double variant that is neither proteolytically active nor
ClpA/X-binding competent (ClpPV6Ainac) (Figure 1B). For the
purpose of detecting association between ClpA and ClpP, we
also included a ClpP variant carrying a tryptophan residue, 508–516, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 509
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ClpAP and ClpXP Architectural Symmetry(ClpPE14W) that reports on binding to the chaperone (Gribun
et al., 2005; Kress et al., 2007).
Combining ClpP(V6A/wt) and ClpP(wt/wt) with ClpA
or ClpX Enables Direct Comparison of 2:1 and 1:1 ClpAP
or ClpXP Complexes
We used a combination of methods to confirm the formation of
asymmetric ClpP particles that can associate only with one
ClpA or ClpX. Assembly of symmetric and asymmetric ClpAP
complexes was followed by recording light-scattering time
traces (Figure 2A). For both symmetric as well as asymmetric
ClpP particles, a 2-fold excess of ClpA rings over ClpP particles
was used. The 1:1 ClpAP complex is about 40% smaller than the
symmetric 2:1 ClpAP complex (0.8 MDa versus 1.3 MDa).
Consistent with formation of a 1:1 complex rather than a 2:1
particle, the trace corresponding to ClpP(V6A/wt) (Figure 2A,
red trace) gave a signal significantly lower compared to the trace
obtained with ClpP(wt/wt) (blue trace). A similar signal difference
was observed when excess amounts of ClpX were used (data
not shown). There was no signal increase when ClpP(V6A/V6A)
was mixed with ClpA under the same conditions (black trace).
We also visualized ClpP(wt/wt) and ClpP(V6A/wt) in the
presence of excess amounts of ClpA using electron microscopy
(EM) (Figure 2B). ClpP(wt/wt) formed symmetric 2:1 complexes
with ClpA, whereas ClpP(V6A/wt) formed only 1:1 complexes.
All other generated asymmetric complexes also formed only
1:1 complexes when mixed with excess amounts of ClpA (data
not shown). In electron micrographs, 2:1 ClpAP complexes are
present predominantly as side views. In contrast, 1:1 complexes
Figure 2. Asymmetric ClpP(V6A/wt) Forms
1:1 ClpAP Complexes in the Presence
of ClpA
(A) The increase in scattered light intensity moni-
tored after rapid mixing of 0.1 mM ClpP(wt/wt)
(blue trace), ClpP(V6A/wt) (red trace), or
ClpP(V6A/V6A) (black trace) with 0.2 mM preas-
sembled ClpA molecules.
(B) Negative-stain electron microscopy images of
ClpP(V6A/wt) (upper panel) and ClpP(wt/wt) (lower
panel) in the presence of excess amounts of ClpA.
(C) The oligomeric state of ClpP(V6A/wt) mixed
with ClpA in a 1:1 ratio (red line) or of wild-type
ClpP mixed with ClpA in a 1:1 (dashed blue line)
or 2:1 ratio (solid blue line) analyzed by analytical
gel filtration.
(D) The time course assembly of 2:1 or 1:1 ClpAP
complexes monitored by rapid mixing of 0.1 mM
ClpP(E14W/E14W) (blue trace) or 0.2 mM
ClpP(V6A/E14W) (red trace) with 0.2 mM ClpA
(Wfree), a tryptophan-free ClpA variant.
are present in side views as well as top
views, making it difficult to assess
whether all ClpP and ClpA associated to
form 1:1 ClpAP.
To determine the homogeneity of the
assembled complexes, we performed
analytical gel-filtration chromatography
(Figure 2C). ClpA and ClpP(wt/wt) applied
in a 2:1 ratio on a Superose 6 PC gel-
filtration column formed predominantly 2:1 ClpAP particles
(blue line). ClpA mixed with equimolar amounts of ClpP(V6A/wt)
resulted in predominantly 1:1 ClpAP complexes (red line),
whereas ClpP(wt/wt) under the same conditions resulted in
a mixture of 2:1 and 1:1 ClpAP complexes together with
unbound ClpP particles (dashed blue line).
A tryptophan-free variant of ClpA and a ClpP variant with an
engineered tryptophan were used to follow the association of
ClpA with ClpP by fluorescence (Kress et al., 2007). We tested
association of ClpP that can bind two ClpA rings and of ClpP
that can only bind one ClpA ring in a stopped-flow fluorescence
device (Figure 2D). To keep the number of binding sites constant,
two times higher amounts of asymmetric ClpP(V6A/E14W) were
used than of ClpP(wt/wt). There is an overlay of association time
traces obtained with the symmetric Clp(E14W/E14W) particle
upon mixing with ClpA (Figure 2D, blue trace) and those obtained
with the asymmetric ClpP(V6A/E14W) particle that can bind ClpA
from only one side (red trace). The mild cooperativity observed
for wild-type ClpAP complex formation (Kress et al., 2007) influ-
ences the ratio of 2:1 versus 1:1 ClpAP complexes formed, but
not the overall association kinetics observed here. Identical
kinetics of 2:1 and 1:1 ClpAP association enabled us to directly
compare substrate processing by these two complexes.
One 2:1 ClpAP/XP Is Equivalent to Two 1:1 ClpAP/XP
Complexes in Substrate Degradation under
Steady-State Conditions
To test for possible benefits of having symmetrically built
complexes with two ClpA or ClpX rings bound to one ClpP510 Structure 17, 508–516, April 15, 2009 ª2009 Elsevier Ltd All rights reserved
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ClpAP and ClpXP Architectural SymmetryTable 1. Relative Degradation Rate of Various Substrates by ClpAP and ClpXP Complex Variants
Relative Degradation Rate (%)
[ClpP] (mM) Formed Complex lRssrA GFPssrA k-Casein FRliGFP ClpA
0.1 ClpAP(wt/wt) 100.0 ± 8.1 100.0 ± 3.3 100.0 ± 4.1 100.0 ± 5.2 100.0
0.1 ClpAP(V6A/wt) 51.6 ± 5.1 49.5 ± 4.1 - 53.4 ± 3.2 -
0.2 ClpAP(V6A/wt) 104.6 ± 8.3 97.1 ± 5.0 109.1 ± 8.0 102.6 ± 5.1 101.5
0.2 ClpAP(V6Ainac/wt) 92.6 ± 8.8 98.9 ± 4.9 85.9 ± 6.9 90.5 ± 4.5 96.0
0.2 ClpAP(V6A/inac) 65.2 ± 5.2 57.4 ± 4.6 67.1 ± 5.4 60.4 ± 3.0 63.0
0.5 ClpXP(wt/wt) 100.0 ± 1.7 100.0 ± 4.9
0.5 ClpXP(V6A/wt) 48.7 ± 5.2 53.7 ± 6.6
1.0 ClpXP(V6A/wt) 94.9 ± 1.5 98.2 ± 3.5
1.0 ClpXP(V6Ainac/wt) 105.0 ± 1.2 96.8 ± 3.1
1.0 ClpXP(V6A/inac) 86.0 ± 2.0 94.9 ± 2.7
For each substrate, an average degradation rate of three measurements was determined under steady-state conditions and is shown relative to the
wild-type 2:1 ClpAP or ClpXP complexes. ClpA autodegradation rate was determined as described previously (Maglica et al., 2008). In all reactions,
0.2 mM ClpA or 1 mM ClpX was used.particle, we measured substrate degradation of five different
substrates by symmetric 2:1 ClpAP/XP complexes and
compared it with equal and double amounts of the asymmetric
1:1 ClpAP/XP molecules under steady-state conditions (Table 1).
The investigated substrates for ClpAP were: the ssrA-tagged
N-terminal domain of l repressor (lRssrA) and GFP (GFPssrA),
the unstructured model substrate k-casein, and an N-end rule
model substrate (FRliGFP). In addition, ClpA itself was used as
an autodegradation substrate. ClpXP was only investigated
with lRssrA and GFPssrA because ClpX does not recognize
k-casein nor N-end rule proteins as substrates. Despite the
fact that the different substrates vary greatly in their recognition
motif, thermodynamic stability, size, and domain structure, the
degradation experiments with all probed substrates showed
that ClpP(wt/wt) and twice the amount of ClpP(V6A/wt) were
equivalent when mixed with the same amounts of ClpA or
ClpX. This means that a symmetric 2:1 ClpAP or ClpXP complex
is twice as active compared to a 1:1 ClpAP or ClpXP complex. To
exclude the possibility that this 2-fold higher activity is in part due
to an increase in affinity for the substrate when two chaperones
are present, we recorded Michaelis-Menten plots of lRssrA
degradation for ClpP(wt/wt) and ClpP(V6A/wt) in the presence
of excess amounts of ClpA (Figure 3). We found that the
apparent affinity is unchanged between ClpAP(wt/wt) and
ClpAP(V6A/wt) whereas the catalytic turnover at saturation is
doubled.
Both bound chaperones translocate substrates into the ClpP
cylinder simultaneously and independently. To investigate
whether individual reaction steps, namely substrate binding,
unfolding, translocation, or degradation, are affected when two
chaperones interact with a single protease, anisotropy and
FRET-based single-turnover assays were used. The FRET
system is based on a model substrate, lRssrA, carrying
a FRET pair at different positions to track the various activities
in real time. In all our measurements, concentrations were
chosen such that a single 2:1 ClpAP/XP is compared to two
1:1 ClpAP/XP complexes to keep the amounts of chaperones
and substrates constant.Structure 17Fluorescence anisotropy measurements with fluorescein-
labeled lRssrA were used to follow the binding and unfolding
by the 2:1 and 1:1 ClpAP machinery (Figure 4A). The binding
was analyzed in a stopped-flow device in the presence of ATPgS
to allow kinetic separation of binding and subsequent unfolding
and translocation. There is an overlay of traces obtained with
ClpAP complexes having ClpP(wt/wt) (Figure 4A, blue trace)
and ClpP(V6A/wt) (red trace) upon mixing with lRssrA. This
demonstrates that 2:1 and 1:1 ClpAP complexes can bind
Figure 3. The 1:1 ClpAP Complex Has the Same Affinity but a 2-Fold
Lower kcat Compared to the 2:1 ClpAP Complex
Initial degradation rates of fluorescently labeled lRssrA followed by the
increase in fluorescence upon degradation by 0.05 mM ClpP(wt/wt) (blue) or
Clp(V6A/wt) (red) in the presence of 0.15 mM ClpA. The lines represent the fit
to the Michaelis-Menten equation [ClpAP(wt/wt): kcat = 8.7 ± 0.3 min
1, Km =
1.7 ± 0.2 mM; ClpAP(V6A/wt): kcat = 4.3 ± 0.3 min
1, Km = 1.7 ± 0.3 mM]., 508–516, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 511
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ClpAP and ClpXP Architectural SymmetryFigure 4. Substrate Processing by 2:1 and
Twice the Amount of 1:1 ClpAP Complexes
(A) Interaction of 2 mM lRssrA labeled with fluores-
cein-5-maleimide with 1 mM 2:1 (blue) or 2 mM 1:1
(red) ClpAP complexes followed by stopped-flow
fluorescence anisotropy.
(B) Unfolding and translocation kinetics in the
context of the whole reaction cycle, monitored
for 2:1 or 1:1 ClpAP complexes upon rapid mixing
with ATP and lRssrA carrying acceptor and donor
fluorophores far from each other in the primary
sequence but close in the native structure.
(C) The translocation time course of lRssrA
processed by 2:1 or 1:1 ClpAP complexes upon
rapid mixing with ATP. The ClpP subunits are
hydrolysis inactive and carry a single donor fluoro-
phore per ClpP double ring that causes a FRET
efficiency increase upon interaction with acceptor
fluorophore covalently linked to lRssrA.
(D) The degradation activity of the reaction cycle
by 2:1 or 1:1 ClpAP monitored by cleavage of
lRssrA modified with donor and acceptor fluoro-
phores positioned close in primary sequence
upon rapid mixing with ATP.
The translocation (C) and degradation (D) reac-
tions were incubated in ATPgS for 1.5 hr before
mixing with ATP to allow substrate binding and
unfolding.substrates equally well, permitting us to directly compare 1:1 and
2:1 complexes in subsequent steps of substrate degradation.
To compare the behavior of the two types of complexes in
unfolding and translocation, a model substrate was used with
a donor and an acceptor label positioned close in tertiary structure
but far away in the primary sequence, resulting in a FRET effi-
ciency decrease upon substrate unfolding and further decrease
upon substrate translocation and degradation (Figure 4B). The
two traces corresponding to 2:1 and 1:1 ClpAP complexes (blue
and red trace, respectively) show identical kinetics upon mixing
with model substrate and ATP, demonstrating that a single 2:1
ClpAP complex behaves as two 1:1 molecules. The measured
time-dependent behavior for the 2:1 and 1:1 ClpXP complexes
also indicated that one 2:1 complex is equivalent to two 1:1
complexes (data not shown). Both ClpA and ClpX can, therefore,
supply the protease ClpP simultaneously with substrates.
We also monitored translocation directly for the 2:1 and 1:1
ClpAP complexes using another FRET probe, where the
acceptor label is located on a single cysteine of the model
substrate and the donor label is positioned inside the chamber
of proteolytically inactive ClpP (Reid et al., 2001) (Figure 4C).
The substrate and degradation complex were first incubated in
ATPgS to allow binding and unfolding of substrate which occurs
due to slow ATPgS hydrolysis. The translocation reaction was
then started by rapid mixing with ATP. Because ClpX hydrolyzes
ATPgS very efficiently (Burton et al., 2003), this reaction was
performed only with the ClpAP complex. The obtained translo-
cation time traces look similar but not identical for symmetric
2:1 ClpAP and asymmetric 1:1 ClpAP complexes (Figure 4C,
blue and red trace, respectively). There is no decrease in the512 Structure 17, 508–516, April 15, 2009 ª2009 Elsevier Ltd All righoverall translocation rate when substrate is translocated from
two ClpA chaperones into the same ClpP chamber. In fact, the
reaction even appears somewhat slower with two 1:1 ClpAP
compared to just one 2:1 ClpAP complex. According to a random
distribution of donor label across the 14 cysteines in the ClpP
double ring, in some complexes the donor label will be located
in the ring distal from the location of substrate entry. This label
will be quenched only after the substrate has passed into the
second half of the chamber. As the substrate will already show
some affinity to the inactive peptide cleavage binding grooves
on the first ring, it will be somewhat slower to quench the label
on the other ring. In case of the symmetric 2:1 ClpAP particle
this is not an issue, because the quenching substrate enters
the chamber from both sides.
To determine whether a single 2:1 ClpAP complex can degrade
substrates as efficiently as two 1:1 ClpAP complexes, a probe re-
porting on translocation and degradation was used (Figure 4D).
This probe carries a FRET pair positioned very close in the
primary sequence, resulting in a FRET efficiency decrease upon
cleavage of any peptide bond in between the two fluorophores.
Still, because degradation is much faster than translocation, the
obtained kinetic traces predominantly reflect the translocation
step of the reaction cycle. In contrast to the translocation setup,
both the 2:1 and 1:1 complexes contain fully active ClpP particles
with two equivalent rings resulting in an immediate signal
decrease irrespective through which ring the substrate enters.
ClpA and ClpP were first incubated with substrate in the presence
of ATPgS to allow the 2:1 or 1:1 ClpAP complexes to assemble
and to bind and unfold the substrate. The reaction was then initi-
ated by rapid mixing with ATP. The time traces for degradation ofts reserved
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ClpAP and ClpXP Architectural Symmetrythe model substrate by one 2:1 ClpAP and two 1:1 ClpAP
complexes overlay (Figure 4D, blue and red trace, respectively),
supporting simultaneous degradation of substrates translocated
from both ClpA rings into the ClpP double ring.
Increased ATPase Activity of ClpA Upon Addition of
ClpP(V6A/inac) Points to a Concerted Conformational
Change of ClpP Rings
To investigate the influence of a hydrolysis-inactive ring within the
ClpP double-ring structure, we generated asymmetric ClpP
complexes that have an inactivated ring positioned proximal or
distal to ClpA (Figure 1B). We first examined the influence of
various asymmetric ClpP particles on ClpA and ClpX ATPase
activities by continuous spectrophotometric ATPase assays
(Figure 5). We observed an 30% increase in ATPase activity
of ClpA when proteolytically active ClpP(wt/wt) was present. No
such stimulation was observed in the presence of inactive
ClpP, no matter whether ClpA was bound on one end only, as
in ClpP(V6Ainac/inac), or on both ends, as in ClpP(inac/inac).
Interestingly, the two asymmetric ClpP particles with only one
proteolysis-competent ring, ClpP(V6A/inac) and ClpP(V6Ainac/
wt), can stimulate ClpA ATPase activity to a similar extent as
the fully active complexes. The stimulation of ATPase activity in
both cases reaches 90% of the rate observed with fully active
ClpP(wt/wt), even though in the case of ClpP(V6A/inac) the prote-
olysis-inactive ring interacts with the ClpA chaperone. This points
to a concerted conformational change of the whole ClpP particle
regardless of which ring is inactive and binds to ClpA. There is no
difference in ClpA ATPase stimulation in the presence of ClpP
that binds ClpA from one side, as in ClpP(V6A/wt), or both sides,
as in Clp(wt/wt), which was expected because in both cases both
Figure 5. ATPase Activity of ClpA and ClpX
Determined in the Presence of Different
ClpP Variants
The ATP hydrolysis rate of ClpA and ClpX (0.2 mM)
in the presence of symmetric (0.1 mM) or asym-
metric (0.2 mM) ClpP variants was recorded under
saturating ATP concentration (5 mM) using
a continuous spectrophotometric ATPase assay.
The error bars represent standard errors deter-
mined from three independent measurements.
rings are proteolytically active. In contrast
to ClpA, ClpX ATPase activity is reduced
(50%) in the presence of both fully active
and inactive ClpP particles, demon-
strating that the same protease core can
exert different effects on the alternative
chaperones.
The overall reaction rate of ClpAP and
ClpXP complexes that contained one
hydrolysis-deficient ring was assayed
under steady-state conditions as with
fully active ClpP particles (Table 1). In
the case where one of the ClpP rings
was inactive, the overall reaction rate
was slowed down only mildly compared
to the fully active complex [compare
ClpP(V6Ainac/wt) and ClpP(V6A/inac) with ClpP(V6A/wt)], even
though these complexes have only half of the peptidase activity
(data not shown). The inactivation of the ring which directly binds
to ClpA or ClpX, ClpP(V6A/inac), showed the largest effect. This
is probably due to trapping of the substrate in the inactivated
proteolytic sites before it can bind to active subunits of the distal
ring and be degraded. This effect was not observed with ssrA-
tagged substrates for the ClpXP complex, possibly because
previous steps are slower than the retardation of unfolded
substrate in the inactive substrate binding grooves.
DISCUSSION
Chaperone-proteases are generally composed of stacked rings
organized in a symmetrical structure with chaperones flanking
the protease cylinder at both ends. In this study, we investigated
the influence of the described architectural symmetry on the
activity of such complexes by generating ClpP double rings,
with the individual rings featuring different properties.
To examine the influence of a second chaperone ClpA or ClpX
bound to a ClpP particle versus just a single associated ClpA or
ClpX ring, we generated an asymmetric ClpP double ring in
which one ring was ClpA/X-binding incompetent, ClpP(V6A/wt).
Such a ClpP particle is only capable of forming asymmetric
1:1 ClpAP or ClpXP complexes. We observed the same affinity
of ClpA toward an ssrA-tagged substrate independent of
whether or not another substrate is bound to the chaperone on
the opposite end of the protease (Figure 4A). This is in agreement
with the electron microscopic observation that substrates can be
bound on both ends of a symmetrical 2:1 ClpAP and ClpXP
chaperone-protease (Ortega et al., 2000, 2002).Structure 17, 508–516, April 15, 2009 ª2009 Elsevier Ltd All rights reserved 513
Structure
ClpAP and ClpXP Architectural SymmetryThe measured steady-state degradation rates for the
symmetric 2:1 ClpAP/XP complex and twice the amount of asym-
metric 1:1 ClpAP/XP complex were the same within error of the
experiment, regardless which substrate was used (Table 1).
Similar experiments have previously been performed with 2:1
and 1:1 complexes for both ClpAP and ClpXP (Maurizi et al.,
1998; Ortega et al., 2002). In these two studies, specific activities
of 2:1 chaperone-proteases were obtained by limiting either
ClpA/X or ClpP in the presence of an excess of the other compo-
nent. In contrast to our results, the second chaperone in the
ClpAP study contributed little additional activating effect on
casein degradation (Maurizi et al., 1998). However, a 2:1 ClpXP
complex was shown to have two times higher activity than a 1:1
complex if lO was used as a protein substrate or FAPHMALVPV
as a peptide substrate (Ortega et al., 2002). Also, the 20S protea-
some, when sealed from one end and thus only able to process
substrates from one side, works at half the rate of a complex
where substrate can be bound and processed from both ends
(Hutschenreiter et al., 2004). There are two possible explanations
for this observation. The simplest explanation is that substrates
can go through the chaperone-protease reaction cycle, including
the unfolding, translocation, and degradation steps, at both sides
simultaneously and independently. This is supported by EM data
that show that 2:1 ClpAP complexes and bound substrate
tracked at different stages of the reaction cycle display perfect
symmetry between the two 2:1 ClpAP ends (Ishikawa et al.,
2001). This was also shown for the 20S proteasome (Hutschen-
reiter et al., 2004; Sharon et al., 2006). Another explanation was
proposed based on EM data obtained with the 2:1 ClpXP
complex (Ortega et al., 2002). Here, alternating translocation of
substrates coming from the two bound ClpX chaperones was
observed. Based on this observation and considering that
2:1 ClpXP is two times more active than 1:1 ClpXP, it was
proposed that translocation can be initiated twice as often in
the 2:1 ClpXP.
To investigate each ClpAP-mediated activity in the reaction
cycle, we made use of a FRET-based real-time method. In the
context of the full reaction pathway, a single symmetric 2:1
ClpAP complex is equivalent to two asymmetric 1:1 ClpAP
complexes (Figure 4B). The same result was obtained when
the 2:1 and 1:1 ClpXP complexes were compared in degradation
of the unfolding probe demonstrating that architectural
symmetry exhibits the same effect on both the ClpXP and ClpAP
complex. The translocation probe that allowed tracking of the
translocation step in the context of the inactive ClpP particle
showed time traces with very similar, but not identical, kinetics
(Figure 4C). The observed differences are most likely due to
the statistical distribution of the donor label inside the ClpP
particle with respect to the substrate entering the cavity.
Nevertheless, these differences suggest that substrates are
predominantly engaged and degraded by the ClpP ring they
enter first.
It has long been known that the ATPase activity of ClpA is
stimulated in the presence of ClpP and protein substrates
through an allosteric signal across the ClpA/ClpP ring-ring
interface (Maurizi, 1991). This stimulation occurred only with
proteolysis-competent ClpP particles and was not seen in the
absence of substrates and chemically inactivated ClpP (Maurizi,
1991). Recently, it was shown that ClpP stimulates ClpA ATPase514 Structure 17, 508–516, April 15, 2009 ª2009 Elsevier Ltd All righactivity regardless of whether the substrate protein is present or
not (Hinnerwisch et al., 2005). We also observed this stimulation
in the presence of active ClpP, whereas hydrolysis-inactive ClpP
was unable to stimulate ClpA ATPase activity. The comparison of
symmetric and asymmetric 2:1 and 1:1 ClpAP complexes,
respectively, showed that the two ‘‘halves’’ of the symmetric
chaperone-protease complex act simultaneously and largely
independently of one another. It was, therefore, interesting to
test how the system would react when the ClpP particle itself
showed asymmetry with respect to proteolytic activity. In partic-
ular, we wanted to test whether the distal ClpP ring of the ClpP
particle in an asymmetric ClpAP complex could still have an
effect on the ClpA ATPase activity. Interestingly, whereas
symmetric inactive ClpP particles, ClpP(inac/inac), cannot
stimulate ClpA ATPase activity, both ClpP particles carrying
one inactive ring stimulated ATPase activity to the same extent
(to 90% of the activity found with ClpPwt) no matter to which
ring, active or inactive, ClpA was bound (Figure 5). If the two rings
were completely independent of one another, only the hydro-
lysis-active ring should stimulate ClpA. Nevertheless, because
we see the same extent of activity in both cases, this indicates
that there must be an allosteric effect coming from the active
to the inactive ring and vice versa resulting in a concerted confor-
mational change of the whole ClpP particle. Several studies have
reported evidence for two or more conformations that a ClpP
particle adopts (Bewley et al., 2006; Gribun et al., 2005; Jennings
et al., 2008; Kim et al., 2001; Kress et al., 2007; Maurizi, 1991).
These two states potentially correspond to a proteolysis-active
mode and a product-release mode during which proteolysis
could be inhibited. For Mycobacterium tuberculosis ClpP1, it
was shown that the presence of large side pores affects the posi-
tion of the active side residues abolishing proteolysis (Ingvarsson
et al., 2007). The other possibility was recently suggested by
Jennings et al. (2008), whose kinetic studies suggest that the
interaction of the ClpP N terminus with ClpA and substrates
results in stimulated hydrolysis. Based on the presented data,
we propose that ClpP in its active state stimulates ATPase
activity of both bound ClpA chaperones, resulting in stimulated
translocation of substrates. When allosteric effects cause ClpP
to change its conformation such that its active sites are no longer
functional, such as, for example, peptide release, there is
a decrease in ATPase stimulation of ClpA.
In conclusion, architectural symmetry enables 2:1 ClpAP
and ClpXP to degrade substrates at twice the rate of an asym-
metric 1:1 ClpAP/XP complex. The two ClpP rings adopt the
same conformational state by a concerted conformational
change. The architectural two-fold symmetry across the
proteolytic cylinder thus represents the most efficient opera-
tional state for these large degradation machines: the 2:1
complex achieves the same rates as two 1:1 complexes at
a lower synthetic cost.
EXPERIMENTAL PROCEDURES
Plasmids
The ClpX overexpressing plasmid was a gift from Michael Maurizi. The V6A
point mutation was introduced in clpPwt and mclpPi34C by the QuikChange
protocol (Stratagene) and verified by DNA sequencing to give clpPV6A and
clpPV6Ainac. Both variants also carry a tobacco etch virus (TEV) cut sitets reserved
Structure
ClpAP and ClpXP Architectural Symmetryfollowed by a His6 tag on the C terminus obtained by site-directed insertion
mutagenesis.
Protein Purification
ClpA, ClpAWfree, ClpX, ClpPwt, ClpPE14W, mClpPi34C, ClpS, GFPssrA,
FRliGFP, k-casein, lR92CssrA, lR9C79CssrA, and lR4C13CssrA were
purified as described (Cranz-Mileva et al., 2008; Kress et al., 2007; Maglica
et al., 2008). ClpPV6A and ClpPV6Ainac were expressed in BL21(DE3) cells
from expression vectors under control of the T7 promoter. They were purified
using a HiTrap chelating column (GE Healthcare) according to the manufac-
turer’s protocol. ClpA, ClpX, ClpP, and all variants were stored in 50 mM
HEPES (pH 7.5), 0.3 M KCl, 2 mM EDTA, and 15% (v/v) glycerol (buffer S).
Protein concentrations were determined by absorbance measurements at
280 nm. ClpA and ClpX concentrations are referred to as hexamer concentra-
tion, and that of ClpP is referred to as concentration of tetradecamer.
Preparation of ClpPasy Complex
ClpPV6A-His (15 mM) was incubated with 60 mM ClpPwt in 50 mM HEPES
(pH 7.5) and 0.7 M KCl for 1 hr at room temperature (RT) to separate double
rings into single rings. Glycerol, water, and imidazole were then added to the
mixture to give 15% glycerol, 0.3 M KCl, and 50 mM imidazole final concentra-
tion and were then again incubated at RT for 1 hr to allow reassociation of the
rings. The mixture was then applied on a HiTrap chelating column, washed
with the same buffer containing 50 mM imidazole, and eluted with buffer
containing 1 M imidazole. The eluted fractions containing ClpPV6A-His and
ClpP(V6A-His/wt) were passed over a PD-10 column equilibrated with
50 mM HEPES (pH 7.2), 50 mM KCl, 2 mM EDTA, and 15% glycerol and
then dialyzed against the same buffer. ClpP(V6A-His/wt) was separated from
ClpPV6A-His by using an anion-exchange Mono Q column (GE Healthcare).
The remaining His tag was cleaved off with TEV protease. ClpP(V6A/wt) was
then separated from the TEV protease, which itself carries a His tag, on a
HiTrap chelating column. Pure ClpP(V6A/wt) complex was afterward trans-
ferred into buffer S and stored at 80C. ClpPasy complexes ClpP(V6A/
E14W), ClpP(V6Ainac/wt), ClpP(V6A/inac), and ClpP(V6Ainac/inac) were ob-
tained according to the same protocol. All steps of the protocol were followed
by 15% SDS-PAGE electrophoresis, and the purity of the final ClpPasy
complexes was confirmed by mass spectroscopy. To test the ring-ring
stability, we incubated ClpP(V6A-His/wt) at 0C in buffer S for 6 hr, 22 hr,
28 hr, 2 days, and 7 days, and reapplied the samples on an Ni-chelating
column. We could neither observe untagged ClpP(wt/wt) in the concentrated
flowthrough nor could we detect an increase in the intensity of the upper
band representing ClpPV6A-His after elution with imidazole. This demon-
strates that no dissociation-reassociation has taken place.
Light Scattering
ClpA (0.2 mM) assembled in 1 mM ATPgS was mixed with 0.1 mM ClpP(V6A/
V6A), ClpP(V6A/wt), or ClpP(wt/wt) in 50 mM HEPES (pH 7.5), 0.3 M KCl,
20 mM MgCl2, 15% (v/v) glycerol, and 1 mM DTT (buffer R). The time course
was followed in an SX-20 MV stopped-flow spectrometer with both excitation
and emission wavelengths set at 360 nm at 23C.
Electron Microscopy
Negative-stain electron microscopy was performed as described (Kessel
et al., 1995). Specimens were viewed in a Zeiss Leo912 transmission electron
microscope operating at 120 kV at a magnification of 31,5003.
Analytical Gel Filtration
Reactions containing 2 mM ClpA and 1 mM ClpP(wt/wt) or 2 mM ClpP(V6A/wt)
or ClpP(wt/wt) were incubated for 10 min at RT in buffer R supplemented with
1 mM ATPgS and were then applied on a Superose 6PC 2.4 ml (GE Healthcare)
size-exclusion column equilibrated in the same buffer. Elution of proteins was
followed at 227 nm.
Formation of ClpAP Complex
ClpAWfree (0.1 mM) was mixed with 0.05 mM ClpP(E14W/E14W) or 0.1 mM
ClpP(V6A/E14W) in buffer R supplemented with 1 mM ATPgS. The association
reaction was monitored at 23C in an SX-20 MV stopped-flow spectrometer as
described (Kress et al., 2007).Structure 17,Binding of lR9C79CssrA to 2:1 and 1:1 ClpAP Complex
ClpAP was incubated for 10 min in buffer R supplemented with 1 mM ATPgS
before mixing with 2 mM fluorescently labeled lR9C79CssrA. The association
reaction was monitored at 23C in an SX-20 MV stopped-flow spectrometer.
The excitation wavelength was set to 490 nm and an emission filter with cutoff
at 515 nm was used.
FRET-Based Real-Time Rapid-Kinetic Fluorescence Measurements
The kinetics of unfolding, translocation, and degradation was followed at 23C
in an SX-20 MV stopped-flow spectrometer with excitation wavelength set to
340 nm and emission at 475 nm. FRET efficiency was calculated according to
the formula FRETef = 1  FDA/FD, where FDA and FD are the fluorescence
intensities of the donor in the presence and absence of the acceptor, respec-
tively. Donor (1,5-IAEDANS; 5-({2-[(iodoacetyl)amino]ethyl}amino)naphtha-
lene-1-sulfonic acid) and acceptor (fluorescein-5-maleimide) fluorophores
were in all reactions covalently linked to engineered cysteine residues. All
measurements were performed in buffer R in the presence of the ATP regen-
eration system. For the unfolding/translocation reactions, ClpAP that had been
assembled in ATPgS for 10 min was rapidly mixed with ATP and ssrA-tagged
model substrate carrying either the florescence donor, lR9C79C-D, or both
the donor and acceptor fluorophores, lR9C79C-DA. Concentrations after
mixing were 2 mM 2:1 ClpAP(wt/wt) or 4 mM 1:1 ClpAP(V6A/wt), 0.5 mM fluores-
cently labeled lRssrA, 7 mM ATP, and 0.5 mM ATPgS. In the translocation
reaction, ClpA and inactive ClpP variants carrying donor fluorophore [ClpP
(inac/inac)-D or ClpP(V6Ainac/inac)-D] were incubated with ssrA-tagged
substrate (lR92C or lR92C-A) in the presence of ATPgS for 1.5 hr to allow
ClpAP formation as well as binding and unfolding of lRssrA variants. The
reaction was then started by 1:1 rapid mixing with ATP. Concentrations after
mixing were 2 mM 2:1 ClpAP(inac/inac)-D or 4 mM 1:1 ClpAP(V6Ainac/inac)-D,
6 mM lR92C or lR92C-A, 5 mM ATP, and 0.5 mM ATPgS. Similarly, the
degradation reactions containing ClpA and ClpP [ClpP(wt/wt) or ClpP(V6A/
wt)] were incubated with ATPgS for 1.5 hr in the presence of ssrA-tagged
model substrate carrying either the florescence donor, lR4C13C-D, or both
the donor and acceptor fluorophores, lR4C13C-DA, before starting the
reaction by 1:1 rapid mixing with ATP. Concentrations after mixing were
1 mM 2:1 ClpAP(wt/wt) or 2 mM 1:1 ClpAP(V6A/wt), 2 mM lR4C13C-D or
lR9C13C-DA, 5 mM ATP, and 0.5 mM ATPgS.
Degradation Assay of Model Substrates
Degradation of lRssrA, GFPssrA, FRliGFP, k-casein, and ClpA by ClpAP was
carried out as described previously (Cranz-Mileva et al., 2008; Maglica et al.,
2008; Weber-Ban et al., 1999). All fluorescence measurements were carried
out on a PTI Quantamaster QM-7 spectrofluorimeter. In all steady-state reac-
tions, ClpA (0.2 mM) and ClpP(wt/wt) (0.1 mM) or ClpP asymmetric complexes
(0.1 or 0.2 mM) yielding either equivalent or double amounts of 1:1 ClpAP
complexes were incubated with GFPssrA (10 mM), FRliGFP (5 mM), fluores-
cein-labeled lRssrA (5 mM), or k-casein (5 mM) in the presence of 5 mM ATP
with regeneration system in buffer R at 23C. In the reactions with ClpXP, 1
mM ClpX, 0.5 mM ClpP(wt/wt), and 0.5 or 1 mM various asymmetric ClpP
were mixed with 20 mM fluorescein-labeled lRssrA or GFPssrA. The degrada-
tion reactions for the Michaelis-Menten measurements were started by addi-
tion of lR4C13C-DA (0.5–10 mM) and 5 mM ATP to a reaction mixture contain-
ing 0.05 mM ClpP(wt/wt) or ClpP(V6A/wt) and 0.15 mM ClpA in buffer R
supplemented with 1 mM ATPgS. The increase in donor fluorescence upon
degradation of lR4C13C-DA was followed at 23C with excitation and emis-
sion wavelengths set at 340 and 475 nm, respectively.
Continuous Spectrophotometric ATPase Assay
The ATPase activity of ClpA in the presence of different ClpP variants was
measured as described (Rieger et al., 1997). All measurements were per-
formed in buffer R supplemented with 5 mM ATP at 23C in a Cary UV-vis
spectrophotometer (Varian).
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